Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293382 · ClinicalTrials.gov registry record
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 30
- Enrollment target
NCT02293382 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT02293382 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective is to perform a retrospective chart review to generate data to evaluate the clinical characteristics and course of disease progression of MPS IIIB.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293382
The ClinicalTrials.gov registry entry for NCT02293382 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02293382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293382 about?
NCT02293382 is a clinical study titled "A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB". The objective is to perform a retrospective chart review to generate data to evaluate the clinical characteristics and course of disease progression of MPS IIIB.
What is the current status of trial NCT02293382?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-07. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02293382?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.